Yang downgraded the rating on NPS Pharmaceuticals (NASDAQ ... Gattex U.S. launch in 2013 and anticipation of bigger Natpara opportunity resulted in strong stock performance. Now trading at ~17.2x EV/'14 revenue (vs. ~16.1x for BMRN …
NPS Pharmaceuticals (Nasdaq: NPSP) announced that NASDAQ has halted trading of the company’s common stock. The U.S. Food and Drug Administration’s (FDA) Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) is …
NPS Pharmaceuticals Inc., which agreed to buy a rival, Enzon Pharmaceuticals Inc., for $770 million in stock, said the companies had called off the takeover after failing to agree on a final price. NPS wanted to renegotiate the terms of the …
BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc. (NASDAQ ... net proceeds of approximately $106.8 million from a recent public offering of common stock. “The success of our recent equity offering, which raised $107 …
Shire plc (LSE: SHP, NASDAQ: SHPG) announces the successful completion of the tender offer for all of the outstanding shares of NPS Pharmaceuticals ... any shares held by NPS Pharma as treasury stock (other than any shares held in …
The deal, in which Alexion will pay cash and stock, values Synageva at more than twice its ... and Ireland-based Shire …
NPS Pharmaceuticals, Inc. (NASDAQ ... Naked short selling is the illegal act of short selling a stock when no …
NPS Pharmaceuticals (NPSP), for example ... Good luck finding a big drug stock that exciting. The projected growth rates for Pfize (PFE)r, Merck (MRK) and J&J (JNJ) are all in the single-digits. So it's no wonder why investors are crazy …
Stock futures are climbing higher ... (ITProPortal) World Business Headlines: Shire has agreed to buy NPS
The Irish drug maker Shire has agreed to acquire NPS Pharmaceuticals for $5.2 billion ... For NPS, the sale comes as the company was enjoying its richest stock market valuation in more than a decade, making it an opportune time to sell.